Acta Presents "EU and UK REACH Developments and Compliance Priorities" Webinar
Acta Presents "EU and UK REACH Developments and Compliance Priorities" Webinar
PR Newswire
WASHINGTON, Oct. 15, 2026
WASHINGTON, Oct. 15, 2026 /PRNewswire/ -- The Acta Group (Acta®) is pleased to present "EU and UK REACH Developments and Compliance Priorities," a complimentary webinar examining recent developments under European Union (EU) Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and United Kingdom (UK) REACH and their practical implications for companies operating in European markets. The webinar will be presented on November 3, 2026, from 11:00 a.m. - 12:00 p.m. (EST). Register here: https://lawbc.zoom.us/webinar/register/2017920905333/WN_HvHgKDazSJegRczmOYTJfQ
During this webinar, Christine M. Palermo, Ph.D., DABT, Director of Regulatory Sciences, Acta; Emma Louise Jackson, Manager, UK REACH, Acta; Max L. Moseley, MSc, Regulatory Scientist, Acta; and Lynn L. Bergeson, President, Acta, will provide insight into the latest developments affecting EU REACH implementation, including the European Chemicals Agency's (ECHA) emerging compliance and enforcement priorities. The program will review recent developments under the UK REACH Alternative Transitional Registration Model (ATRm) and give attendees several practical examples of how companies are ensuring compliance in the UK. The presenters will also use case studies to illustrate specific scenarios in which registration or notification obligations may not be readily apparent when considering EU REACH and UK REACH alone, reflecting jurisdiction-specific requirements and regulatory nuances.
Topics Covered:
- EU REACH Developments
- REACH implementation reform and evolving regulatory priorities
- Recent enforcement initiatives and compliance check trends
- UK REACH Developments and Practical Compliance
- Current registration deadlines
- The ABCs of UK REACH compliance
- What companies need to do now
- Jurisdictional Chemical Management Nuances
- Case studies examining how the territorial scope of EU REACH shapes global compliance planning
Acta is a global scientific and regulatory consulting firm that assists companies making or using chemicals or chemical products with strategic commercialization planning and complex product registration and compliance matters in North America, South America, Europe, the Middle East, and Asia.
With offices in the United States, UK, and EU, and with a highly experienced staff that has actively assessed REACH and its implications since its inception, Acta is uniquely well-suited to assist innovators to monetize their creations and to guide new and existing registrants in complex regulatory, policy, and commercial challenges.
SOURCE The Acta Group
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Sell for Tax-Loss Harvesting
33 Undervalued Stocks to Buy Before the Market Shifts Again
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
Ask the Analyst: What Is the Best Source for Low-Risk Tax-Free Income?
United States